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Ethics and development
In the past, ethical conduct was considered an integral part of academia and an unquestionable value, 
whereas today we see the mobilization of movements designed to prevent its demise. It may be a heartbreak-
ing panorama, but one requiring urgent attention to reverse and educational practices to restore, rather than 
resorting to tears. To this end, we participated in a number of recent events for scientific editors, as represen-
tatives of the Brazilian Journal of Pharmaceutical Sciences: III Seminar for Scientific Editors of USP; The 
Libraries of USP, Ethics and Copyrights; XIII ENEC, National Meeting of Scientific Editors, on the theme 
Integrity and Ethics in scientific publishing, and the IV Satellite Seminar for Senior Editors, both organized 
by the Brazilian Association for Scientific Editors, ABEC, as well as the II Brazilian Meeting on Research 
Integrity, Science and Publication Ethics - II BRISPE, organized by Coppe/UFRJ. In these events, we identi-
fied the urgent need for greater engagement with the issue. According to Leite (2009), there is a consensus 
in the intellectual and academic world that pressure to publish, the semi-industrial organization of scientific 
research and the competition between academic journals have led to a lowering of ethical standards in the field, 
with increased frequency of fraud, manipulation and lapses in judgment. We cannot allow these situations to 
occur if we want to maintain the credibility of BJPS in the national and international scientific community.
We also know that a growing number of institutions are recognizing and promoting the scientific output 
of their teaching staff, insisting on publication of new articles that are oftentimes of questionable scientific 
merit. We observe that the concerns of Torresi et al. (2008) are still valid: pressures to increase the level of 
individual, institutional or countrywide publication cannot be used as an excuse for the lack of ethics in 
publications. In this respect, the Brazilian Journal of Pharmaceutical Sciences legitimizes its fight for qua-
lity and standing in the international community by flatly rejecting the use of self-citation to increase impact 
factors. Clearly, this is not in keeping with the 70-year history of publishing of the School of Pharmaceutical 
Sciences of the University of São Paulo.
We are proof that reputable conduct also generates results and development. Looking at the statistical 
data, we can identify clear growth in our visibility. In 2011, we recorded an increase in legitimate citations, 
compared to the previous year. These data are given in Table I, which also shows the number of citations of 
previous years, allowing us to evaluate the cited growth. 
Aware of the risks involved in changing our editorial policies, in 2009 we adopted English as the official 
language, which, as expected, resulted in a reduction in the number of manuscripts received for evaluation 
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and possible publication in the Brazilian Journal of Pharmaceutical Sciences (Figure 1). However, in 2011, 
a significant recuperation of this particular measure was observed. Although the number of submissions has 
ultimately fallen, initially we have published the same average number of articles (Figure 2). Furthermore, 
there is increased interest from foreign authors, which indicates greater visibility of the journal internation-
ally (Figure 3). On the other hand, this fact also means we must be extra vigilant against fraud, plagiarism, 
self-plagiarism, authorship and author responsibilities, duplicate submissions and other procedures that may 
infringe upon codes of ethics. We highlight the need to recognize and improve the system of peer review 
by increasing the number of specialists, and providing them with the tools to detect plagiarism, some avail-
able electronically, such as Google Search and Google Scholar, as well as the use of electronic tools such 
TABLE I - Numerical Data - SciELO Basis - Content and Citations
Year of publication 2002 2003 2004 2005 2006 2007 2008 2009* 2010 2011
Nº of issues 4 4 4 4 4 4 4 4 4 4
Nº of articles 45 47 58 53 58 68 79 96 87 94
Nº of granted citations 1924 1285 1827 1878 2153 2189 2902 2960 2902 2963
Nº of received citations 17 21 20 21 32 55 96 7 20 44
Average articles per issue 11.25 11.75 14.50 13.25 14.50 17.00 19.75 24.00 21.75 23.5
* Changed to: Brazilian Journal of Pharmaceutical Sciences.
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as CrossCheck®, in addition to other initiatives. We also stress the importance of making reviewers aware 
that human judgment will always be necessary. BJPS will spare no effort to encourage and support greater 
involvement of its reviewers in the pursuit of fraud.
It is important to note also that authors must display good conduct, as clearly defined in protocols of 
the Scientific Publication Ethics Committee (COPE), an entity founded in 1997, whose objective is to define 
better ethical practices for scientific publications, guidelines not only for authors, but also, and especially, for 
editors themselves, members of the editorial staff, owners of journals and publishers (COPE, n.d.).
The publishing of a scientific journal should be a source of pride not only for the editor and editorial 
staff, but also the entire scientific community which it represents and that, indirectly, consolidates its position 
as a reliable vehicle for dissemination.
Another pertinent point on this line of rigorous analysis of articles was the finding that, over the last 
four years, there has been an increase in the number of rejected manuscripts (Figure 4). Over these past four 
years, 361 articles were published. Of this total, around 91% were original articles and roughly 9% were 
review articles (Figure 5).
The numerical data certainly show us the direction to take. New goals emerge that clamor to be 
implemented, such as the need to broaden the audience of BJPS internationally in the field of pharmaceuti-
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cal sciences; publication of special and thematic editions with the participation of foreign specialists; greater 
speed in the editorial process, specialized personnel training for the executive editorial board with a view to 
efficient continuity of services and effective automation of processes, among other challenges.
Nonetheless, we remain optimistic, the university is optimistic, and today Brazil is an emerging leader 
in research. These are indeed good times! It is up to us to take on leading roles in the development of phar-
maceutical sciences in Brazil in a competent manner and contribute to real and sustainable growth!
As a partner in these endeavors, I would like to thank Prof. Dr. Elizabeth Igne Ferreira, scientific 
editor of the Brazilian Journal of Pharmaceutical Sciences, for the opportunities given me, for the respect 
of associate editors and the publication committee for the work carried out by the executive editorial board, 
for which I am responsible, and for the support and confidence of the Dean of the School of Pharmaceutical 
Sciences of the University São Paulo, Prof. Dr. Jorge Mancini Filho.
Dedication, persistence and conduct shall determine the flavor of the fruits and the pride of the harvest.
 Leila Rangel de Carvalho Aranha
 Executive Editor
 Brazilian Journal of Pharmaceutical Sciences
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